New clinical trial results, a growing battle for the GLP-1 pill market, and major questions about affordability and access. We’re breaking it all down LIVE on On The Pen.
Find obesity and metabolic clinical trials that may be relevant to you, then connect directly with the study team when contact information is available.
Find My Trial18,595 recruiting studies tracked across 1105 treatments — sourced from ClinicalTrials.gov.
The most-read On The Pen stories, ranked by reader engagement.
Novo will aslo add the tagline “Lasting health starts now”… Here’s how they could actually make that a reality.
The agency is not approving these peptides or permanently adding them to the 503A Bulks List. It is creating a temporary enforcement bridge while FDA finishes that process.
On The Pen's flagship podcast — obesity medicine, unfiltered.
Obesity.News
Breaking GLP-1 news, drug development, access updates, and patient-centered analysis, all in one place.
Empowering you to have better conversations with your doctor.
On The Pen covers obesity medicine from the patient's side of the exam table — GLP-1s, access, and the science, reported plainly.
Sponsors & Partners
